Search research articles
Contact Us
Filters
Showing results (91-100 of 200) with videos related to
Page
of 20
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 26, 2026
Evaluating Associations Between Cumulative Use of Chronic Liver Injury-Inducing Antiretroviral Therapy and Hepatocellular Carcinoma, By Chronic Liver Disease Status
Jessie Torgersen, Craig W Newcomb, Dean M Carbonari, et al.
AIDS (London, England)
|
September 26, 2009
Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not men
Vincent Lo Re, Giovanni Guaraldi, Mary B Leonard, et al.
JAMA Network Open
|
November 6, 2024
Risk Score for Hepatocellular Cancer in Adults Without Viral Hepatitis or Cirrhosis
Ysabel C Ilagan-Ying, Kirsha S Gordon, Janet P Tate, et al.
Hepatology (Baltimore, Md.)
|
February 5, 2021
The Impact of Direct-Acting Antiviral Therapy on End-Stage Liver Disease Among Individuals with Chronic Hepatitis C and Substance Use Disorders
Haesuk Park, Xinyi Jiang, Hyun Jin Song, et al.
Journal of Viral Hepatitis
|
June 6, 2020
Determinants of stigma among patients with hepatitis C virus infection
M Elle Saine, Julia E Szymczak, Tyler M Moore, et al.
Journal of General Internal Medicine
|
October 6, 2020
Correction to: Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting Antivirals
Albert Do, Denise A Esserman, Supriya Krishnan, et al.
Journal of General Internal Medicine
|
April 29, 2020
Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting Antivirals
Albert Do, Denise A Esserman, Supriya Krishnan, et al.
European Journal of Clinical Pharmacology
|
October 28, 2016
Evaluation of methods to estimate missing days' supply within pharmacy data of the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN)
Kirsten J Lum, Craig W Newcomb, Jason A Roy, et al.
Open Forum Infectious Diseases
|
July 7, 2018
Absolute Insurer Denial of Direct-Acting Antiviral Therapy for Hepatitis C: A National Specialty Pharmacy Cohort Study
Charitha Gowda, Stephen Lott, Matthew Grigorian, et al.
The Journal of Infectious Diseases
|
September 23, 2006
A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression
Robert Gross, Benita Yip, Vincent Lo Re, et al.
Page
of 20
Search research articles
Search
Showing results (91-100 of 200) with videos related to
Sort By:
Page
of 20
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 26, 2026
Evaluating Associations Between Cumulative Use of Chronic Liver Injury-Inducing Antiretroviral Therapy and Hepatocellular Carcinoma, By Chronic Liver Disease Status
Jessie Torgersen, Craig W Newcomb, Dean M Carbonari, et al.
AIDS (London, England)
|
September 26, 2009
Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not men
Vincent Lo Re, Giovanni Guaraldi, Mary B Leonard, et al.
JAMA Network Open
|
November 6, 2024
Risk Score for Hepatocellular Cancer in Adults Without Viral Hepatitis or Cirrhosis
Ysabel C Ilagan-Ying, Kirsha S Gordon, Janet P Tate, et al.
Hepatology (Baltimore, Md.)
|
February 5, 2021
The Impact of Direct-Acting Antiviral Therapy on End-Stage Liver Disease Among Individuals with Chronic Hepatitis C and Substance Use Disorders
Haesuk Park, Xinyi Jiang, Hyun Jin Song, et al.
Journal of Viral Hepatitis
|
June 6, 2020
Determinants of stigma among patients with hepatitis C virus infection
M Elle Saine, Julia E Szymczak, Tyler M Moore, et al.
Journal of General Internal Medicine
|
October 6, 2020
Correction to: Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting Antivirals
Albert Do, Denise A Esserman, Supriya Krishnan, et al.
Journal of General Internal Medicine
|
April 29, 2020
Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting Antivirals
Albert Do, Denise A Esserman, Supriya Krishnan, et al.
European Journal of Clinical Pharmacology
|
October 28, 2016
Evaluation of methods to estimate missing days' supply within pharmacy data of the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN)
Kirsten J Lum, Craig W Newcomb, Jason A Roy, et al.
Open Forum Infectious Diseases
|
July 7, 2018
Absolute Insurer Denial of Direct-Acting Antiviral Therapy for Hepatitis C: A National Specialty Pharmacy Cohort Study
Charitha Gowda, Stephen Lott, Matthew Grigorian, et al.
The Journal of Infectious Diseases
|
September 23, 2006
A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression
Robert Gross, Benita Yip, Vincent Lo Re, et al.
Page
of 20